Previous 10 | Next 10 |
Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire SAN JOSE, Calif. , Jan. 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and in...
Aurora Mobile (JG) +85% after company inks partnership with new EV manufactures.Aemetis (AMTX) +61% after company acquired ~20% ownership of Nevo Motors.Hudson Capital (HUSN) +40% after issuing revenue guidance for FreightHub.Sportsman's Warehouse Holdings (SPWH)...
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine Novel technology developed by Cleveland Clinic researchers PR Newswire SAN JOSE, Calif. , Dec. 21, 2020 /PRNewswire/ -- Anixa Biosciences, Inc....
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing SAN JOSE, Calif. , Dec. 14, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of c...
Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...
Gainers: Immutep (IMMP) +204%, Greenwich LifeSciences (GLSI) +60%, TG Therapeutics (TGTX) +37%, SELLAS Life Sciences (SLS) +28%, Anixa Biosciences (ANIX) +18%.Losers: Xenetic Biosciences (XBIO) -32%, Oncternal Therapeutics (ONCT)-26%, GeoVax L...
Anixa Biosciences ([[ANIX]] +4.5%) has entered into a license agreement with Cleveland Clinic for exclusive, world-wide rights to an ovarian cancer vaccine technology. The development-stage vaccine targets the extracellular domain of anti-mullerian hormone receptor 2 (AMHR2-ED), that appears ...
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology Anixa to Host a Conference Call Thursday, December 3, 2020, 1:15 p.m. PT to Discuss Program PR Newswire SAN JOSE, Calif., Dec. 1, 2020 SAN JOSE, Calif. ...
Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine PR Newswire SAN JOSE, Calif., Nov. 23, 2020 SAN JOSE, Calif. , Nov. 23, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on t...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe earnings season marches on even as investors head into next week with a fair amount of uncertainty on election scenar...
News, Short Squeeze, Breakout and More Instantly...
Anixa Biosciences Inc. Company Name:
ANIX Stock Symbol:
NASDAQ Market:
Anixa Biosciences Inc. Website:
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , July 17, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment an...
Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, I...